These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9635474)

  • 21. Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.
    Halimi G; Duplan L; Bideau C; Iniesta D; Berthézène P; Oddoze C; Verdier JM; Michel B; Bergé-Lefranc JL
    Neuroreport; 2000 Nov; 11(16):3599-601. PubMed ID: 11095526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India.
    Chandak GR; Sridevi MU; Vas CJ; Panikker DM; Singh L
    Hum Biol; 2002 Oct; 74(5):683-93. PubMed ID: 12495082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia.
    Rodriguez Martin T; Calella AM; Silva S; Munna E; Modena P; Chiesa R; Terrevazzi S; Ruggieri RM; Palermo R; Piccoli F; Confalonieri R; Tiraboschi P; Fragiacomo C; Quadri P; Lucca U; Forloni G
    Dement Geriatr Cogn Disord; 2000; 11(5):239-44. PubMed ID: 10940674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.
    Licastro F; Pedrini S; Govoni M; Pession A; Ferri C; Annoni G; Casadei V; Veglia F; Bertolini S; Grimaldi LM
    Neurosci Lett; 1999 Aug; 270(3):129-32. PubMed ID: 10462111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives.
    Farrer LA; Cupples LA; van Duijn CM; Kurz A; Zimmer R; Müller U; Green RC; Clarke V; Shoffner J; Wallace DC
    Ann Neurol; 1995 Nov; 38(5):797-808. PubMed ID: 7486872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study.
    Ganguli M; Chandra V; Kamboh MI; Johnston JM; Dodge HH; Thelma BK; Juyal RC; Pandav R; Belle SH; DeKosky ST
    Arch Neurol; 2000 Jun; 57(6):824-30. PubMed ID: 10867779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
    Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
    Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.
    Graff-Radford NR; Green RC; Go RC; Hutton ML; Edeki T; Bachman D; Adamson JL; Griffith P; Willis FB; Williams M; Hipps Y; Haines JL; Cupples LA; Farrer LA
    Arch Neurol; 2002 Apr; 59(4):594-600. PubMed ID: 11939894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis.
    Liu M; Bian C; Zhang J; Wen F
    Sci Rep; 2014 Mar; 4():4383. PubMed ID: 24632849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.
    Jun G; Naj AC; Beecham GW; Wang LS; Buros J; Gallins PJ; Buxbaum JD; Ertekin-Taner N; Fallin MD; Friedland R; Inzelberg R; Kramer P; Rogaeva E; St George-Hyslop P; ; Cantwell LB; Dombroski BA; Saykin AJ; Reiman EM; Bennett DA; Morris JC; Lunetta KL; Martin ER; Montine TJ; Goate AM; Blacker D; Tsuang DW; Beekly D; Cupples LA; Hakonarson H; Kukull W; Foroud TM; Haines J; Mayeux R; Farrer LA; Pericak-Vance MA; Schellenberg GD
    Arch Neurol; 2010 Dec; 67(12):1473-84. PubMed ID: 20697030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
    Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
    Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    González RD; Gomes I; Gomes C; Rocha R; Durães L; Sousa P; Figueruelo M; Rodríguez M; Pita C; Hornero R; Gómez C; Lopes AM; Pinto N; Martins S
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
    Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
    J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
    D'Onofrio G; Panza F; Seripa D; Sancarlo D; Paris F; Cascavilla L; Urbano M; Gravina C; Fontana A; Solfrizzi V; Pellegrini F; Pilotto A
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):1062-70. PubMed ID: 21905100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease.
    Kamboh MI; Sanghera DK; Aston CE; Bunker CH; Hamman RF; Ferrell RE; DeKosky ST
    Genet Epidemiol; 1997; 14(2):169-80. PubMed ID: 9129962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Hydroxytryptamine 6 receptor (5-HT(6)) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country.
    Alvarez-Alvarez M; Galdos L; Fernández-Martínez M; Gómez-Busto F; García-Centeno V; Arias-Arias C; Sánchez-Salazar C; Rodríguez-Martínez AB; Zarranz JJ; de Pancorbo MM
    Neurosci Lett; 2003 Mar; 339(1):85-7. PubMed ID: 12618306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
    Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
    Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.
    Helisalmi S; Mannermaa A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H
    Neurosci Lett; 1997 Aug; 231(1):56-8. PubMed ID: 9280167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.